Sue Sha

2.0k total citations
18 papers, 1.5k citations indexed

About

Sue Sha is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Sue Sha has authored 18 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Sue Sha's work include Diabetes Treatment and Management (11 papers), Pancreatic function and diabetes (9 papers) and Magnesium in Health and Disease (2 papers). Sue Sha is often cited by papers focused on Diabetes Treatment and Management (11 papers), Pancreatic function and diabetes (9 papers) and Magnesium in Health and Disease (2 papers). Sue Sha collaborates with scholars based in United States, Germany and Belgium. Sue Sha's co-authors include David Polidori, Paul Rothenberg, Tim Heise, Atalanta Ghosh, Leona Plum‐Mörschel, Nicole Vaccaro, Damayanthi Devineni, Theodore P. Ciaraldi, Sunder Mudaliar and Robert R. Henry and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Diabetes Care and Annals of the New York Academy of Sciences.

In The Last Decade

Sue Sha

18 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Sue Sha United States	16	1.3k	735	432	220	207	18	1.5k
Søren S. Lund Germany	22	1.5k 1.2×	635 0.9×	659 1.5×	112 0.5×	126 0.6×	50	1.9k
Anna Maria Langkilde Sweden	15	1.9k 1.5×	901 1.2×	1.0k 2.4×	147 0.7×	153 0.7×	21	2.1k
Carolina Solis‐Herrera United States	18	1.3k 1.1×	828 1.1×	791 1.8×	168 0.8×	68 0.3×	38	1.7k
Nicole Vaccaro United States	17	619 0.5×	408 0.6×	272 0.6×	97 0.4×	83 0.4×	25	945
Arnaud Bastien United States	8	1.0k 0.8×	515 0.7×	568 1.3×	76 0.3×	52 0.3×	15	1.2k
Robert S. Busch United States	15	1.1k 0.9×	391 0.5×	492 1.1×	52 0.2×	68 0.3×	45	1.3k
Giacomo Rossitto Italy	17	551 0.4×	558 0.8×	214 0.5×	78 0.4×	134 0.6×	52	1.2k
Ole Hother‐Nielsen Denmark	26	924 0.7×	493 0.7×	878 2.0×	202 0.9×	81 0.4×	52	2.0k
David P. Sonne Denmark	21	783 0.6×	604 0.8×	502 1.2×	309 1.4×	59 0.3×	53	1.6k
Panai Song China	14	353 0.3×	279 0.4×	372 0.9×	114 0.5×	101 0.5×	27	904

Countries citing papers authored by Sue Sha

Since Specialization

Citations

This map shows the geographic impact of Sue Sha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sue Sha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sue Sha more than expected).

Fields of papers citing papers by Sue Sha

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sue Sha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sue Sha. The network helps show where Sue Sha may publish in the future.

Co-authorship network of co-authors of Sue Sha

This figure shows the co-authorship network connecting the top 25 collaborators of Sue Sha. A scholar is included among the top collaborators of Sue Sha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sue Sha. Sue Sha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

Cusi, Kenneth, Fernando Bril, Diana Barb, et al.. (2018). Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes. Diabetes Obesity and Metabolism. 21(4). 812–821. 137 indexed citations

Gilbert, Richard E., Christian W. Mende, Ujjwala Vijapurkar, et al.. (2017). Effects of Canagliflozin on Serum Magnesium in Patients With Type 2 Diabetes Mellitus: A Post Hoc Analysis of Randomized Controlled Trials. Diabetes Therapy. 8(2). 451–458. 35 indexed citations

Gilbert, Richard E., Christian W. Mende, Ujjwala Vijapurkar, et al.. (2016). Effects of Canagliflozin (CANA) on Serum Magnesium (Mg) in Patients With Type 2 Diabetes Mellitus (T2DM). Canadian Journal of Diabetes. 40(5). S31–S31. 1 indexed citations

Leiter, Lawrence A., Thomas Först, David Polidori, et al.. (2015). Effect of canagliflozin on liver function tests in patients with type 2 diabetes. Diabetes & Metabolism. 42(1). 25–32. 101 indexed citations

Chen, Xia, Pei Hu, Nicole Vaccaro, et al.. (2015). Pharmacokinetics, Pharmacodynamics, and Safety of Single-Dose Canagliflozin in Healthy Chinese Subjects. Clinical Therapeutics. 37(7). 1483–1492.e1. 25 indexed citations

Rosenthal, Norm, Gary Meininger, Kirk Ways, et al.. (2015). Canagliflozin: a sodium glucose co‐transporter 2 inhibitor for the treatment of type 2 diabetes mellitus. Annals of the New York Academy of Sciences. 1358(1). 28–43. 79 indexed citations

Mamidi, Rao N. V. S., Filip Cuyckens, Jie Chen, et al.. (2014). Metabolism and Excretion of Canagliflozin in Mice, Rats, Dogs, and Humans. Drug Metabolism and Disposition. 42(5). 903–916. 56 indexed citations

Polidori, David, Sue Sha, Tim Heise, et al.. (2014). Effect of canagliflozin, a sodium glucose co‐transporter 2 inhibitor, on C‐peptide kinetics. Clinical Pharmacology in Drug Development. 4(1). 12–17. 7 indexed citations

Sha, Sue, David Polidori, Tim Heise, et al.. (2014). Effect of the sodium glucose co‐transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus. Diabetes Obesity and Metabolism. 16(11). 1087–1095. 199 indexed citations

10.

Sha, Sue, David Polidori, Jaya Natarajan, et al.. (2014). Pharmacodynamic differences between canagliflozin and dapagliflozin: results of a randomized, double‐blind, crossover study. Diabetes Obesity and Metabolism. 17(2). 188–197. 73 indexed citations

11.

Devineni, Damayanthi, Prasarn Manitpisitkul, Nicole Vaccaro, et al.. (2014). Effect of canagliflozin, a sodium glucose co-transporter 2 inhibitor, on the pharmacokinetics of oral contraceptives, warfarin, and digoxin in healthy participants. International Journal of Clinical Pharmacology and Therapeutics. 53(1). 41–53. 16 indexed citations

12.

Polidori, David, Sue Sha, Atalanta Ghosh, et al.. (2013). Validation of a Novel Method for Determining the Renal Threshold for Glucose Excretion in Untreated and Canagliflozin-treated Subjects With Type 2 Diabetes Mellitus. The Journal of Clinical Endocrinology & Metabolism. 98(5). E867–E871. 74 indexed citations

13.

Polidori, David, Sue Sha, Sunder Mudaliar, et al.. (2013). Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion. Diabetes Care. 36(8). 2154–2161. 217 indexed citations

14.

Sha, Sue, Damayanthi Devineni, David Polidori, et al.. (2011). Canagliflozin, a novel inhibitor of sodium glucose co‐transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects. Diabetes Obesity and Metabolism. 13(7). 669–672. 255 indexed citations

15.

Schmidt, Stephan, Sreedharan Sabarinath, April Barbour, et al.. (2009). Pharmacokinetic-Pharmacodynamic Modeling of the In Vitro Activities of Oxazolidinone Antimicrobial Agents against Methicillin-ResistantStaphylococcus aureus. Antimicrobial Agents and Chemotherapy. 53(12). 5039–5045. 16 indexed citations

16.

Becker, R. H. A., Sue Sha, Annke Frick, & Robert J. Fountaine. (2006). The Effect of Smoking Cessation and Subsequent Resumption on Absorption of Inhaled Insulin. Diabetes Care. 29(2). 277–282. 51 indexed citations

17.

Rave, Klaus, S. Bott, Lutz Heinemann, et al.. (2005). Time-Action Profile of Inhaled Insulin in Comparison With Subcutaneously Injected Insulin Lispro and Regular Human Insulin. Diabetes Care. 28(5). 1077–1082. 122 indexed citations

18.

Uehlinger, Dominik E., P Weidmann, Sue Sha, et al.. (1989). Distinct hemodynamic and renal effects of calcitonin gene-related peptide and calcitonin in men. American Journal of Physiology-Endocrinology and Metabolism. 257(6). E848–E854. 22 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact